Anuh Pharma (ANUHPHR) — Announcement

📢 Key Event
Q1 FY27 results show revenue growth and margin expansion

🔄 What Changed
ROCE up 326 bps to 19.18%, production up 19.46% to 491 MT

🔮 What's Next
15-20% annual growth rate anticipated

💡 Investor Takeaway
The company is prioritizing higher-value regulated markets to drive margin expansion and sustainable growth without leverage.

Anuh Pharma Limited released its Q1 FY27 investor presentation, highlighting a 3.93% YoY revenue increase to Rs. 193.81 crores and a 41.56% YoY EBITDA rise to Rs. 19.36 crores, driven by higher-value product mix and cost discipline. PAT grew 37.63% YoY to Rs. 11.42 crores with 5.89% margin expansion. Production rose 19.46% to 491 MT, while ROCE improved by 326 bps to 19.18%. The company emphasized its regulated market focus, USFDA/EU GMP clearances, and capacity expansion to 2,400 MTPA, supporting sustainable growth.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANUHPHR ✨ Ask AI About This

About Anuh Pharma Limited (ANUHPHR)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹896.2 Cr P/E: 20.3 ROE: 12.5% ROCE: 17.2% Div Yield: 1.68%

View full ANUHPHR stock details →

📡 Get AI alerts when ANUHPHR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANUHPHR — Free

💡 Ask AI about this filing

"What is the revenue contribution from regulated markets?" "How does 19.18% ROCE compare to industry peers?" "What is the timeline for new product launches?"

Ask AI Free →

📊 More ANUHPHR filings

See all ANUHPHR filings →

🔥 Also filed on 19 August 2026

GOCOLORS Go Fashion (India) Limited Annual Report OIL Oil India Limited Corporate Action GLAXO GlaxoSmithKline Pharmaceuticals Limited Financial Results TIL TIL Limited Financial Results SETUINFRA Setubandhan Infrastructure Limited Financial Results ASALCBR Associated Alcohols & Breweries Ltd. Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANUHPHR files new disclosures

Track ANUHPHR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANUHPHR — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd